Literature DB >> 29157614

POEMS Syndrome: Diagnosis and Investigative Work-up.

Angela Dispenzieri1, Taxiarchis Kourelis2, Francis Buadi2.   

Abstract

POEMS syndrome is a rare paraneoplastic syndrome secondary to a plasma cell dyscrasia. Recognition of a combination of peripheral neuropathy, organomegaly, endocrinopathy, monoclonal plasmaproliferative disorder, skin changes, papilledema, extravascular volume overload, sclerotic bone lesions, thrombocytosis, and Castleman disease is the first step in managing the disease. Increased blood levels of vascular endothelial growth factor are usually confirmatory. This rare disorder should not be missed, especially if the patient has a putative diagnosis of chronic inflammatory polyradiculoneuropathy, a lambda restricted monoclonal gammopathy, and thrombocytosis, and is not responding as expected to immunomodulatory therapy commonly used for chronic inflammatory polyradiculoneuropathy.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Castleman disease; Chronic inflammatory polyradiculoneuropathy; Paraneoplastic; Plasma cell disorder

Mesh:

Substances:

Year:  2018        PMID: 29157614     DOI: 10.1016/j.hoc.2017.09.010

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  7 in total

Review 1.  An update on the diagnosis and management of the polyneuropathy of POEMS syndrome.

Authors:  Federica Cerri; Yuri Matteo Falzone; Nilo Riva; Angelo Quattrini
Journal:  J Neurol       Date:  2018-09-27       Impact factor: 4.849

2.  Characteristics of 1946 Cases of POEMS Syndrome in Chinese Subjects: A Literature-Based Study.

Authors:  Yong Wang; Li-Bo Huang; Yi-Hua Shi; Huan Fu; Zhen Xu; Guo-Qing Zheng; Yan Wang
Journal:  Front Immunol       Date:  2019-06-21       Impact factor: 7.561

3.  Positron Emission Tomography-Computed Tomography in a Case of POEMS Syndrome.

Authors:  Jose Rafael Infante; Lucía García; Juan Ignacio Rayo; Justo Serrano; Manuel Moreno; Amparo Cobo; Pedro Jimenez; Andrés Martínez
Journal:  Indian J Nucl Med       Date:  2019 Jan-Mar

4.  Historical and pathological overview of Castleman disease.

Authors:  Midori Filiz Nishimura; Yoshito Nishimura; Asami Nishikori; Tadashi Yoshino; Yasuharu Sato
Journal:  J Clin Exp Hematop       Date:  2022-04-27

5.  Rib Plasmacytoma Presenting as Progressive Muscle Weakness.

Authors:  Lokeshwaran Madurai Kalimuthu; Prakash Singh; Manish Ora; Sanjay Gambhir
Journal:  Indian J Nucl Med       Date:  2021-03-04

Review 6.  Waldenström macroglobulinemia treatment algorithm 2018.

Authors:  Morie A Gertz
Journal:  Blood Cancer J       Date:  2018-05-01       Impact factor: 11.037

7.  Atypical polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes syndrome without polyneuropathy: A case report.

Authors:  Qiang Li; Fang Xu; Jing-Feng Duan; Yu-Feng Tang
Journal:  Medicine (Baltimore)       Date:  2020-07-02       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.